tert-Butyl 2-bromo-3,4-difluorobenzylcarbamate

Catalog No. :
ACLQGU871
CAS No. :
2231675-56-0
Molecular Formula :
C12H14BrF2NO2
Molecular Weight :
322.15

IUPAC Name:tert-butyl (2-bromo-3,4-difluorobenzyl)carbamate

tert-Butyl 2-bromo-3,4-difluorobenzylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$324.00Login to see priceInquiryInquiry
100mg98%$550.00Login to see priceInquiryInquiry
250mg98%$937.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-bromo-3,4-difluorobenzylcarbamate
IUPAC Nametert-butyl (2-bromo-3,4-difluorobenzyl)carbamate
Molecular FormulaC12H14BrF2NO2
Molecular Weight322.15
SMILESO=C(OC(C)(C)C)NCC1=CC=C(F)C(F)=C1Br
InChI KeyFQLWSCBIDFZADP-UHFFFAOYSA-N
Synonymtert-Butyl 2-bromo-3,4-difluorobenzylcarbamate;Carbamic acid, N-[(2-bromo-3,4-difluorophenyl)methyl]-, 1,1-dimethylethyl ester;tert-butyl N-[(2-bromo-3,4-difluorophenyl)methyl]carbamate
CAS No.2231675-56-0
PubChem CID137346974

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLQGU871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJXMY682 route compound structure diagram
    ACJXMY6822231675-44-6 In Stock
  4. Then
  5. ACLQGU871 route product structure diagram
    ACLQGU8712231675-56-0
Inquiry

2. ACLQGU871 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHQO530 route compound structure diagram
    ACEHQO5304248-19-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLQGU871 route product structure diagram
    ACLQGU8712231675-56-0
Inquiry

Comments (0)